Survey on Supplement Use in Mitochondrial Disease

NCT ID: NCT02311257

Last Updated: 2016-09-22

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

162 participants

Study Classification

OBSERVATIONAL

Study Start Date

2014-09-30

Study Completion Date

2015-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to learn about the use of nutritional supplements in patients with mitochondrial disease.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Our goal is to better assess which nutritional supplements are prescribed to patients with mitochondrial disorders, the monitoring obtained and whether any subjective improvements are noted by the patients or their caregivers.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Mitochondrial Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

CROSS_SECTIONAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* NAMDC Clinical Registry or RDCRN Contact Registry participant
* Diagnosis of a mitochondrial disease confirmed by either electron transport chain abnormalities or molecular testing.

Exclusion Criteria

* Lack of participation in NAMDC or RDCRN registries
* Diagnosis of mitochondrial disorder not confirmed by ETC studies or molecular diagnosis
Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

National Institutes of Health (NIH)

NIH

Sponsor Role collaborator

University of South Florida

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Sumit Parikh, MD

Role: STUDY_CHAIR

The Cleveland Clinic

Amel Karaa, MD

Role: STUDY_CHAIR

Massachussetts General Hospital

Michio Hirano, MD

Role: STUDY_CHAIR

Columbia University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of South Florida

Tampa, Florida, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Related Links

Access external resources that provide additional context or updates about the study.

http://www.rarediseasesnetwork.org/namdc/

Rare Diseases Clinical Research Network NAMDC page

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

NAMDC7411

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Glutathione and Fuel Oxidation in Aging
NCT01870193 COMPLETED EARLY_PHASE1